Targeted molecular therapies for cancer: collateral damage?
Publication
, Conference
Allegrezza, M; Rutkowski, M; Stephen, T; Svoronos, N; Tesone, A; Conejo-Garcia, J
Published in: JOURNAL OF IMMUNOLOGY
2013
Duke Scholars
Published In
JOURNAL OF IMMUNOLOGY
ISSN
0022-1767
Publication Date
2013
Volume
190
Related Subject Headings
- Immunology
- 3204 Immunology
- 3101 Biochemistry and cell biology
- 1107 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Allegrezza, M., Rutkowski, M., Stephen, T., Svoronos, N., Tesone, A., & Conejo-Garcia, J. (2013). Targeted molecular therapies for cancer: collateral damage? In JOURNAL OF IMMUNOLOGY (Vol. 190).
Allegrezza, Michael, Melanie Rutkowski, Tom Stephen, Nikos Svoronos, Amelia Tesone, and Jose Conejo-Garcia. “Targeted molecular therapies for cancer: collateral damage?” In JOURNAL OF IMMUNOLOGY, Vol. 190, 2013.
Allegrezza M, Rutkowski M, Stephen T, Svoronos N, Tesone A, Conejo-Garcia J. Targeted molecular therapies for cancer: collateral damage? In: JOURNAL OF IMMUNOLOGY. 2013.
Allegrezza, Michael, et al. “Targeted molecular therapies for cancer: collateral damage?” JOURNAL OF IMMUNOLOGY, vol. 190, 2013.
Allegrezza M, Rutkowski M, Stephen T, Svoronos N, Tesone A, Conejo-Garcia J. Targeted molecular therapies for cancer: collateral damage? JOURNAL OF IMMUNOLOGY. 2013.
Published In
JOURNAL OF IMMUNOLOGY
ISSN
0022-1767
Publication Date
2013
Volume
190
Related Subject Headings
- Immunology
- 3204 Immunology
- 3101 Biochemistry and cell biology
- 1107 Immunology